NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

13 hedge funds and large institutions have $1.7M invested in Northwest Biotherapeutics, Inc. Common stock in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SL
1
Sentinus LLC
Illinois
$1.02M
2
MSAM
2
Moloney Securities Asset Management
Missouri
$204K

Top Sellers

1
AIP
1
Almanack Investment Partners
Pennsylvania
$0
2
CAPTRUST Financial Advisors
2
CAPTRUST Financial Advisors
North Carolina
$0
3
GWI
3
Grace & White Inc
New York
$10K
Name Market Value Shares Shares
Change 		Shares
Change %
SL
1
Sentinus LLC
Illinois
$1.02M 1,194,415 +1,194,415 New
AA
2
Ancora Advisors
Ohio
$355K 497,000 – –
MSAM
3
Moloney Securities Asset Management
Missouri
$204K 285,160 +700 +0.2%
OCG
4
Opus Capital Group
Ohio
$39K 55,150 – –
WJWM
5
Williams Jones Wealth Management
New York
$28K 39,000 – –
LDB
6
Lee, Danner & Bass
Tennessee
$14K 20,000 – –
GWI
7
Grace & White Inc
New York
$10K 14,705 -10,600 -42%
AA
8
AlphaMark Advisors
Kentucky
$10K 14,007 – –
GG
9
Gofen & Glossberg
Illinois
$9K 12,740 – –
ECM
10
Estabrook Capital Management
New York
$5K 7,000 – –
BCWM
11
Bartlett & Co Wealth Management
Ohio
$3.06K 4,292 – –
BC
12
Bartlett & Co
Ohio
$3K 4,292 – –
AIP
13
Almanack Investment Partners
Pennsylvania
– – -22,000 Closed
CAPTRUST Financial Advisors
14
CAPTRUST Financial Advisors
North Carolina
– – -17,624 Closed
HFS
15
Hantz Financial Services
Michigan
$0 250 – –